Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis

<p></p><div> <h3> Background</h3> <p>Colchicine was recently repurposed for the management of coronavirus disease 2019 (COVID-19). This rapid review and meta-analysis aimed to assess colchicine's impact on mortality outcomes in COVID-19 patients.</p> &l...

Full description

Saved in:
Bibliographic Details
Main Author: Mohamed Nabil Elshafei (9960500) (author)
Other Authors: Ahmed El‐Bardissy (14777851) (author), Ahmed Khalil (2132113) (author), Mohammed Danjuma (9960506) (author), Mahmood Mubasher (14570517) (author), Ibrahim Y. Abubeker (9960503) (author), Mouhand F. H. Mohamed (9617052) (author)
Published: 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<p></p><div> <h3> Background</h3> <p>Colchicine was recently repurposed for the management of coronavirus disease 2019 (COVID-19). This rapid review and meta-analysis aimed to assess colchicine's impact on mortality outcomes in COVID-19 patients.</p> <h3> Materials and Methods</h3> <p>We systematically searched PubMed, EMBASE, Google Scholar since their inception till 25/03/2021 for observational or controlled studies that reported mortality as an outcome. The mortality odd ratios were generated with their corresponding 95% confidence intervals utilizing the random-effects model.</p> <h3> Results</h3> <p>Nine studies comprising 5522 patients met our inclusion criteria. Our meta-analysis revealed significantly lower mortality in the colchicine group (OR 0.35, 95% CI 0.25-0.48, I2 0%) compared with controls. A subgroup analysis limited to hospitalized patients (OR 0.35, 95% CI 0.25-0.50, I2 0%) revealed similarly lower mortality in the colchicine group.</p> <h3> Conclusions</h3> <p>This meta-analysis suggests a mortality benefit with colchicine when used in the treatment of COVID-19 patients. The majority of included studies were observational; thus, the findings of this review need to be further supported by the results of ongoing trials.</p> </div><p></p><h2>Other Information</h2> <p> Published in: European Journal of Clinical Investigation<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1111/eci.13645" target="_blank">http://dx.doi.org/10.1111/eci.13645</a></p>